Skip to main content
. 2020 Jan 10;15(1):e0225867. doi: 10.1371/journal.pone.0225867

Table 3. Physician opinion(s) regarding non-medical switching.

Please indicate how much you agree or disagree with each of the following related to non-medical switching and your professional experience % of Physicians Surveyed Responding “Agree Strongly”, “Agree Very Much” or “Agree Somewhat” (95%CI)a % of Physicians Surveyed Responding “Neither Agree Nor Disagree” (95%CI)a % of Physicians Surveyed Responding “Disagree Strongly”, “Disagree Very Much” or “Disagree Somewhat” (95%CI)a
Frustrates me 87.6 (84.4–90.1) 9.6 (7.5–12.6) 2.8 (1.6–4.5)
Forces me to compromise my ethics 49.1 (44.9–53.5) 32.9 (29.0–37.1) 18.0 (14.8–21.4)
Puts me in an uncomfortable situation where I am conflicted between the patient’s needs and the fiscal responsibilities of my practice 69.8 (65.7–73.7) 20.9 (17.5–24.5) 9.3 (7.1–12.2)
Compromises my autonomy in clinical
decision making
82.3 (78.8–85.4) 11.6 (9.2–14.7) 6.1 (4.3–8.4)
Undermines my clinical judgment 74.8 (71.0–78.5) 16.8 (13.8–20.2) 8.4 (6.3–11.1)
Diverts communication time with patients away from other important clinical issues 84.3 (80.8–87.1) 12.1 (9.5–15.2) 3.9 (2.5–5.9)
Undermines a patient’s trust in my ability as a clinician 56.1 (51.7–60.3) 30.8 (26.9–34.9) 13.1 (10.4–16.2)
Results in treatment inconsistent with accepted guidelines 53.5 (49.2–57.8) 32.1 (28.2–36.3) 14.4 (11.6–17.7)
Increases my ability to do what is cost-effective for my patients 39.0 (34.8–43.2) 28.8 (25.0–32.9) 32.2 (28.4–36.5)
Reduces the role of insurance companies in the medication selection process 17.2 (14.3–20.8) 17.5 (14.5–21.0) 65.3 (61.2–69.4)
Forces me to take responsibility for a medication decision made by the insurance company 81.1 (77.5–84.3) 13.9 (11.1–17.1) 5.3 (3.6–7.5)
Please indicate how much you agree or disagree with each of the following statements regarding the insurance process around a non-medical switchb
The process to challenge a non-medical switch is straightforward 17.3 (14.3–20.8) 15.0 (12.2–18.3) 66.9 (62.7–70.9)
The insurance process to challenge a non-medical switch is worth the effort 35.6 (31.6–39.8) 20.6 (17.3–24.3) 43.0 (36.1–44.6)
The insurance process discourages physicians from challenging a non-medical switch 76.7 (72.8–80.1) 14.4 (11.6–17.7) 8.2 (6.1–10.9)
Insurance companies provide clear steps to challenge a non-medical switch 20.4 (17.2–24.1) 20.0 (16.8–23.7) 58.9 (54.6–63.1)
Insurance companies clearly communicate how long it will take to receive a decision about a non-medical switch 17.9 (14.8–21.4) 18.0 (15.0–21.7) 63.2 (59.0–67.3)
Methods for inquiring about the status of a non-medical switch challenge are readily available 20.5 (17.2–24.1) 18.9 (15.7–22.5) 59.1 (54.8–63.3)
I am often put on hold for inconvenient lengths of time when I call insurance companies about my non-medical switch challenge 76.1 (72.2–79.6) 15.1 (12.3–18.5) 7.3 (5.3–9.8)
When I call an insurance company to challenge the non-medical switch, I spend most of my time speaking to a physician who has the requisite specialty or sub-specialty expertise to perform an expert review 19.7 (16.4–23.3) 15.5 (12.7–19.0) 62.0 (57.8–66.2)

aAll percentages are weighted.

bPercentages may sum to less than 100% as respondents were allowed to indicate “don’t know” for this subset of survey items.